首页 | 官方网站   微博 | 高级检索  
     

CD73在结直肠癌组织中的表达及其与临床病理参数的关系
引用本文:付 卫,黄坤蓉,付 敏,黄建宏.CD73在结直肠癌组织中的表达及其与临床病理参数的关系[J].现代肿瘤医学,2019,0(10):1753-1757.
作者姓名:付 卫  黄坤蓉  付 敏  黄建宏
作者单位:1.宜昌市第二人民医院肿瘤外科,湖北 宜昌 443000;2.建始县人民医院消化内科,湖北 宜昌 445300;3.宜昌市第一人民医院普外科,湖北 宜昌 443000
基金项目:湖北省卫生和计划委员会科技发展项目(编号:17003200254)
摘    要:目的:探讨不同分期结直肠癌患者肿瘤组织内CD73表达分布情况及其与患者临床病理参数、预后之间的关系。方法:选取2012年1月至2013年6月于本院就诊并行手术治疗的结直肠癌患者共60例作为研究对象,于术中取其肿瘤组织和癌旁组织样本,使用免疫组化法检测收集的所有样本中CD73分布与表达情况,并分析CD73与结直肠癌患者临床病理参数及预后的关系。结果:TNM分期越高的结直肠癌患者病灶组织CD73阳性率越高(P<0.05),癌旁组织中CD73阳性率明显低于结直肠癌患者(P<0.05);CD73在结直肠癌中的阳性表达率与年龄、组织分化程度无相关(P>0.05);与浸润深度、淋巴结转移和临床分期有重要联系(P<0.05);CD73表达阳性组术后存活时间明显短于阴性组(P<0.05);疾病复发率明显高于阴性组(P<0.05);阳性组5年存活率也明显低于阴性组(P<0.05),提示CD73呈阳性高表达的结直肠癌患者预后往往较差。结论:CD73在结直肠癌患者肿瘤组织中的表达量明显升高,可作为评估患者预后的独立预测因子,临床医师可根据结直肠癌患者病理组织中CD73表达量对其预后进行判断和评估,具有推广价值。

关 键 词:结直肠癌  不同分期  表达分布  相关性

Expression of CD73 in colorectal carcinoma and its relationship with clinicopathologic parameters
Fu Wei,Huang Kunrong,Fu Min,Huang Jianhong.Expression of CD73 in colorectal carcinoma and its relationship with clinicopathologic parameters[J].Journal of Modern Oncology,2019,0(10):1753-1757.
Authors:Fu Wei  Huang Kunrong  Fu Min  Huang Jianhong
Affiliation:1.Department of Oncology,Yichang Second People's Hospital,Hubei Yichang 443000,China;2.Department of Digestive Medicine,Jianshi People's Hospital,Hubei Yichang 445300,China;3.General Surgery,Yichang First People's Hospital,Hubei Yichang 443000,China.
Abstract:Objective:To investigate the distribution of CD73 in patients with different stages of colorectal cancer and its relationship with clinicopathological parameters and prognosis.Methods:A total of 60 patients with colorectal cancer who were treated at our hospital from January 2012 to June 2013 were selected as the study subjects.All patients underwent surgical treatment.During the operation,samples of tumor tissue and adjacent normal tissues were taken and used.The immunohistochemical method was used to detect the distribution and expression of CD73 in all samples collected.The relationship between CD73 and the clinical parameters and prognosis of patients with colorectal cancer was analyzed.Results:The positive rate of CD73 in the lesion tissue of patients with colorectal cancer was higher (P<0.05).The positive rate of CD73 in adjacent normal tissue was significantly lower than that in colorectal cancer (P<0.05).The positive expression rate of CD73 in colorectal cancer was not related to age and histological differentiation (P>0.05).It was significantly associated with depth of invasion,lymph node metastasis,and clinical stage (P<0.05).Postoperative survival time of CD73 positive group was significantly shorter than the negative group (P<0.05).The recurrence rate of the disease was significantly higher than that of the negative group (P<0.05).The five-year survival rate of the positive group was also significantly lower than that of the negative group (P<0.05),suggesting that CD73 was positive and highly expressed,colorectal cancer patients tended to have poor prognosis.Conclusion:The expression of CD73 in colorectal cancer patients was significantly increased.It can be used as an independent predictor of prognosis.Clinicians can judge and evaluate the prognosis of patients with colorectal cancer based on their CD73 expression,which has promotion value.
Keywords:colorectal cancer  different stages  expression distribution  relevance
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号